Setbone Medical
Novel Treatment for Vertebral Compression Fractures
Company Overview
Snapshot
Founded in December 2017 by Royi Kaufmann and Nimrod Kaufmann, Setbone Medical operates with 1–10 employees. The company has raised $1.6 million across two funding rounds from four investors, with The Trendlines Group participating in both rounds. In January 2022, SetBone Medical announced a $1.6 million financing.
Business overview
Setbone Medical is a Health Tech & Life Sciences company developing a novel bone cement for treating vertebral compression fractures (VCF) primarily caused by osteoporosis. Its proprietary acrylic bone cement, Setbone Cement, is designed to overcome the limitations of current cements by providing a safer and more efficient solution for physicians. The product, which is in clinical trial, does not contain toxic monomers, comes in a ready-to-use prefilled cartridge, and features a dual-paste, mix-on injection system allowing extended working time and a low exothermic reaction to prevent tissue damage. The company operates globally, targeting healthcare providers.
Strategic signal
In January 2022, SetBone Medical announced a $1.6 million financing round. This capital infusion signals investor confidence in the company's novel bone cement technology and its potential to address the limitations of existing treatments for vertebral compression fractures, positioning Setbone Medical for continued development and clinical progress.
Log in to access full profile ›Company Intelligence Q&A
- When was Setbone Medical founded?
- Setbone Medical was founded in December 2017 by Royi Kaufmann and Nimrod Kaufmann.
- What is Setbone Medical's primary focus?
- Setbone Medical focuses on developing a novel bone cement for the treatment of vertebral compression fractures (VCF) primarily caused by osteoporosis.
- What was a significant funding event for Setbone Medical?
- In January 2022, SetBone Medical announced a $1.6 million financing round. The Trendlines Group and Chicago ArchAngels were among the investors.
- What are the key features of Setbone Medical's bone cement?
- Setbone Medical's bone cement does not contain toxic monomers, comes in a ready-to-use, prefilled cartridge, and offers a dual-paste, mix-on injection for extended working time and a low exothermic reaction to prevent tissue damage.
- Which investor has participated in multiple funding rounds for Setbone Medical?
- The Trendlines Group has participated in multiple funding rounds for Setbone Medical, including the seed round in December 2017 and the financing round in January 2022.